Current Enterprise Value (EV)
Current share price (P) | $373.63 |
No. shares of common stock outstanding | 45,091,184 |
US$ in thousands | |
Common equity (market value)1 | 16,847,419) |
Add: Class B Preferred Stock, $.01 par value; none issued and outstanding (per books) | —) |
Total equity | 16,847,419) |
Add: Current portion of capital lease obligation (per books) | —) |
Add: Capital lease obligation, net of current portion (per books) | —) |
Total equity and debt | 16,847,419) |
Less: Cash and cash equivalents | 132,818) |
Less: Short-term marketable securities | 625,789) |
Enterprise value (EV) | 16,088,812) |
Based on: 10-K (reporting date: 2022-03-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 373.63 × 45,091,184
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Abiomed Inc. Annual Report.
3 2022 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 235.75 × 45,563,937
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Abiomed Inc. EV increased from 2020 to 2021 but then slightly decreased from 2021 to 2022 not reaching 2020 level. |